Skip to main content

Table 1 Characteristics of IFX-treated patients and untreated healthy controls

From: B cell epitopes on infliximab identified by oligopeptide microarray with unprocessed patient sera

  Patients Untreated controls
Mean age 37 y 35 y
Gender distribution 60 % female 75 % female
Mean ADA level 51 µg/ml <1.25 µg/ml
  1. y years, ADA anti-drug antibody